. 2018 Mar 22;40(3):356–361. doi: 10.1097/FTD.0000000000000506
Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
TABLE 3.
Influence of Each Factor Including CYP2C19 Genotype on Metabolite Ratio
